Risk of asthma in individuals with eosinophilic esophagitis: Population‐based cohort study with sibling analyses

Documenti analoghi

• Dupilumab improves clinical and histologic features of eosinophilic esophagitis prior to 12 weeks of treatment
  di: Twan Sia, et al.
  Pubblicazione: (2024)
• Benralizumab and the integrated management of co‐morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps
  di: Joaquim Mullol, et al.
  Pubblicazione: (2025)
• Bacteria and viruses and clinical outcomes of asthma‐bronchiectasis overlap syndrome: A cohort study
  di: Xiao‐xian Zhang, et al.
  Pubblicazione: (2024)
• Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study
  di: Bernardo Sousa‐Pinto, et al.
  Pubblicazione: (2024)
• T2‐low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross‐sectional study
  di: Konstantinos Porpodis, et al.
  Pubblicazione: (2025)